|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.08 USD | -2.14% |
|
-7.16% | +7.44% |
| Dec. 12 | Bristol Myers: increase in quarterly dividend | CF |
| Dec. 10 | Agilent Cancer Diagnostic Assay Receives Certification to Comply with New EU Regulations | MT |
ETFs positioned on Bristol-Myers Squibb Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 12.97% | 380 M€ | +10.16% | - | |
| 4.99% | 2 M€ | -.--% | ||
| 4.01% | 20 M€ | +16.38% | - | |
| 2.63% | 31 M€ | +32.45% | - | |
| 2.37% | 2 M€ | -25.75% | ||
| 2.08% | 9 M€ | -.--% | - | |
| 1.90% | 16 M€ | -3.37% | ||
| 1.85% | 2 M€ | -.--% | ||
| 1.43% | 5 M€ | -72.95% | - | |
| 1.42% | 9 M€ | -4.31% | - | |
| 1.37% | 26 M€ | +16.85% | - | |
| 1.26% | 752 M€ | +13.25% | ||
| 1.00% | 83 M€ | +19.73% | ||
| 0.99% | 11 M€ | +19.99% | ||
| 0.97% | 36 M€ | +17.68% | - | |
| 0.97% | 412 M€ | +15.33% | - | |
| 0.83% | 115 M€ | +26.18% | ||
| 0.82% | 7 M€ | +12.54% | ||
| 0.80% | 2,795 M€ | +17.41% | ||
| 0.78% | 3 M€ | +15.16% | - | |
| 0.78% | 4 M€ | -.--% | - | |
| 0.78% | 13 M€ | -.--% | - |
Employees
34,100
Sector
Pharmaceuticals
Calendar
2025-02-06
- Q4 2024 Earnings Release
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
56.28USD
Average target price
60.58USD
Spread / Average Target
+7.64%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMY Stock
- ETFs Bristol-Myers Squibb Company